{"id":40097,"date":"2025-08-26T14:56:57","date_gmt":"2025-08-26T06:56:57","guid":{"rendered":"https:\/\/flcube.com\/?p=40097"},"modified":"2025-08-26T14:56:57","modified_gmt":"2025-08-26T06:56:57","slug":"minova-rongzhi-funding-surge-series-b-backed-by-idg-capital","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=40097","title":{"rendered":"Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital"},"content":{"rendered":"\n<p>Nanjing\u2011based <strong>Minova Pharmaceuticals Co., Ltd.<\/strong> closed a <strong>Series\u202fB financing round<\/strong> worth <strong>hundreds of millions of RMB<\/strong>, with <strong>IDG Capital<\/strong> acting as the sole lead investor and <strong>Oriza Seed<\/strong> re\u2011investing. The capital influx is earmarked to fast\u2011track the company\u2019s drug\u2011development pipeline and expand sales of its flagship product, <strong>Rongzhi<\/strong> \u2013 a deoxycholic acid (DCA) injection that dissolves fat.<\/p>\n\n\n\n<p><strong>Overview of the Funding Deal<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Total amount raised<\/strong>: <strong>\u00a5300\u202fmillion\u2013\u00a5400\u202fmillion<\/strong> (exact figure undisclosed)<\/li>\n\n\n\n<li><strong>Lead investor<\/strong>: <strong>IDG Capital<\/strong> \u2013 a major player in China\u2019s biotech ecosystem<\/li>\n\n\n\n<li><strong>Co\u2011investor<\/strong>: <strong>Oriza Seed<\/strong> \u2013 maintaining stake from earlier rounds<\/li>\n\n\n\n<li><strong>Use of proceeds<\/strong>:<\/li>\n<\/ul>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Accelerate clinical development of next\u2011generation DCA\u2011based formulations<\/li>\n\n\n\n<li>Scale up manufacturing capacity for Rongzhi<\/li>\n\n\n\n<li>Expand marketing and distribution in domestic and international consumer\u2011health markets<\/li>\n<\/ol>\n\n\n\n<p><strong>Rongzhi: China\u2019s First Legally Compliant Fat\u2011Dissolving Injection<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Milestone<\/th><th>Date<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td>Company founded<\/td><td><strong>Feb\u202f2021<\/strong><\/td><td>Focus on consumer\u2011health R&amp;D, manufacturing, and sales<\/td><\/tr><tr><td>Product approval<\/td><td><strong>Jun\u202f2024<\/strong><\/td><td>Rongzhi receives China Food and Drug Administration (CFDA) approval as the first legally compliant fat\u2011dissolving injection<\/td><\/tr><tr><td>Market launch<\/td><td><strong>Jun\u202f2024<\/strong><\/td><td>Commercial distribution begins across key Chinese cities<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Rongzhi\u2019s mechanism\u2014injectable DCA that solubilizes triglycerides\u2014offers a non\u2011surgical alternative to liposuction, positioning it within a rapidly growing aesthetic\u2011medicine niche.<\/p>\n\n\n\n<p><strong>Strategic Implications<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>R&amp;D Lead<\/strong>: The new capital will fund Phase\u202fIII trials for an expanded\u2011dose Rongzhi, aiming for broader indications (e.g., localized lipodystrophy).<\/li>\n\n\n\n<li><strong>Market Penetration<\/strong>: With IDG\u2019s network, Minova can enter Southeast Asian markets, leveraging the company\u2019s experience in cross\u2011border pharma sales.<\/li>\n\n\n\n<li><strong>Competitive Edge<\/strong>: Maintaining the first\u2011to\u2011market status in the Chinese fat\u2011dissolving injectable segment provides a moat against emerging generic entrants.<\/li>\n<\/ul>\n\n\n\n<p><strong>Outlook<\/strong><br>Minova\u2019s Series\u202fB round signals strong confidence from seasoned investors in its consumer\u2011health strategy. The company is targeting a <strong>$30\u202fmillion\u2011level revenue milestone for Rongzhi by the end of 2026<\/strong>, propelled by expanded marketing, regulatory approvals in new territories, and a robust pipeline of DCA derivatives.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nanjing\u2011based Minova Pharmaceuticals Co., Ltd. closed a Series\u202fB financing round worth hundreds of millions of&#8230;<\/p>\n","protected":false},"author":1,"featured_media":40102,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[30,20,100,4158],"class_list":["post-40097","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-biotech","tag-finance","tag-medical-aesthetics","tag-minova-pharmaceuticals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Nanjing\u2011based Minova Pharmaceuticals Co., Ltd. closed a Series\u202fB financing round worth hundreds of millions of RMB, with IDG Capital acting as the sole lead investor and Oriza Seed re\u2011investing. The capital influx is earmarked to fast\u2011track the company\u2019s drug\u2011development pipeline and expand sales of its flagship product, Rongzhi \u2013 a deoxycholic acid (DCA) injection that dissolves fat.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=40097\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital\" \/>\n<meta property=\"og:description\" content=\"Nanjing\u2011based Minova Pharmaceuticals Co., Ltd. closed a Series\u202fB financing round worth hundreds of millions of RMB, with IDG Capital acting as the sole lead investor and Oriza Seed re\u2011investing. The capital influx is earmarked to fast\u2011track the company\u2019s drug\u2011development pipeline and expand sales of its flagship product, Rongzhi \u2013 a deoxycholic acid (DCA) injection that dissolves fat.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=40097\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-26T06:56:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2611.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40097#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40097\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital\",\"datePublished\":\"2025-08-26T06:56:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40097\"},\"wordCount\":337,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40097#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/2611.webp\",\"keywords\":[\"Biotech\",\"Finance\",\"Medical aesthetics\",\"Minova Pharmaceuticals\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=40097#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40097\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=40097\",\"name\":\"Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40097#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40097#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/2611.webp\",\"datePublished\":\"2025-08-26T06:56:57+00:00\",\"description\":\"Nanjing\u2011based Minova Pharmaceuticals Co., Ltd. closed a Series\u202fB financing round worth hundreds of millions of RMB, with IDG Capital acting as the sole lead investor and Oriza Seed re\u2011investing. The capital influx is earmarked to fast\u2011track the company\u2019s drug\u2011development pipeline and expand sales of its flagship product, Rongzhi \u2013 a deoxycholic acid (DCA) injection that dissolves fat.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40097#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=40097\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40097#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/2611.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/2611.webp\",\"width\":1080,\"height\":608,\"caption\":\"Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=40097#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital - Insight, China&#039;s Pharmaceutical Industry","description":"Nanjing\u2011based Minova Pharmaceuticals Co., Ltd. closed a Series\u202fB financing round worth hundreds of millions of RMB, with IDG Capital acting as the sole lead investor and Oriza Seed re\u2011investing. The capital influx is earmarked to fast\u2011track the company\u2019s drug\u2011development pipeline and expand sales of its flagship product, Rongzhi \u2013 a deoxycholic acid (DCA) injection that dissolves fat.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=40097","og_locale":"en_US","og_type":"article","og_title":"Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital","og_description":"Nanjing\u2011based Minova Pharmaceuticals Co., Ltd. closed a Series\u202fB financing round worth hundreds of millions of RMB, with IDG Capital acting as the sole lead investor and Oriza Seed re\u2011investing. The capital influx is earmarked to fast\u2011track the company\u2019s drug\u2011development pipeline and expand sales of its flagship product, Rongzhi \u2013 a deoxycholic acid (DCA) injection that dissolves fat.","og_url":"https:\/\/flcube.com\/?p=40097","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-08-26T06:56:57+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2611.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=40097#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=40097"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital","datePublished":"2025-08-26T06:56:57+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=40097"},"wordCount":337,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=40097#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2611.webp","keywords":["Biotech","Finance","Medical aesthetics","Minova Pharmaceuticals"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=40097#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=40097","url":"https:\/\/flcube.com\/?p=40097","name":"Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=40097#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=40097#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2611.webp","datePublished":"2025-08-26T06:56:57+00:00","description":"Nanjing\u2011based Minova Pharmaceuticals Co., Ltd. closed a Series\u202fB financing round worth hundreds of millions of RMB, with IDG Capital acting as the sole lead investor and Oriza Seed re\u2011investing. The capital influx is earmarked to fast\u2011track the company\u2019s drug\u2011development pipeline and expand sales of its flagship product, Rongzhi \u2013 a deoxycholic acid (DCA) injection that dissolves fat.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=40097#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=40097"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=40097#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2611.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2611.webp","width":1080,"height":608,"caption":"Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=40097#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Minova Rongzhi Funding Surge: Series\u202fB Backed by IDG Capital"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/08\/2611.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/40097","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=40097"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/40097\/revisions"}],"predecessor-version":[{"id":40103,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/40097\/revisions\/40103"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/40102"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=40097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=40097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=40097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}